# DHM (Dihydromyricetin) Regulatory Status & Quality Standards Report

**Research Date:** November 9, 2025
**Purpose:** Comprehensive analysis of DHM's legal status, regulatory classification, and quality standards globally

---

## Executive Summary

Dihydromyricetin (DHM) occupies a complex regulatory landscape. While it is sold as a dietary supplement in multiple countries, it lacks explicit GRAS (Generally Recognized as Safe) designation from the FDA and has no approved novel food status in the EU. The ingredient has a strong safety profile based on toxicology studies, but quality standards vary significantly by manufacturer, and third-party certification is rare. Consumers must carefully evaluate products for purity, testing, and appropriate manufacturing standards.

**Key Findings:**
- âœ… **Generally safe** based on toxicology studies (no acute or chronic toxicity)
- âš ï¸ **Regulatory gray area** in US (sold as dietary supplement, but FDA warns against hangover cure claims)
- âŒ **Not approved as novel food in EU** (application pending since 2022)
- âœ… **Approved in Canada** (at least one product has NPN 80122969)
- âš ï¸ **Poor bioavailability** (only 4% oral bioavailability) - formulation matters significantly
- âš ï¸ **No USP monograph** - no official purity/testing standards
- ðŸ”´ **Third-party testing rare** - few products are NSF/USP/ConsumerLab verified

---

## 1. FDA Status (United States)

### Current Regulatory Position

**Status:** Dietary supplement ingredient (not GRAS-designated, not approved drug)

**Key Issues:**
- DHM is sold in the US as a dietary supplement ingredient
- No official GRAS (Generally Recognized as Safe) determination found in FDA databases
- No New Dietary Ingredient (NDI) notification identified for Hovenia dulcis or purified DHM
- **FDA Warning Letters issued (July 2020)** to at least 7 companies selling DHM hangover products

### FDA Enforcement Actions

**Date:** July 23, 2020
**Recipients:** Multiple companies including:
- Ebnsol, Inc (Warning Letter 593771)
- Purple Biosciences, LLC (Warning Letter 593772)

**Violations Cited:**
- Making drug claims ("prevents," "treats," or "cures" hangovers) for dietary supplements
- Only FDA-approved drugs can make disease prevention/treatment claims
- Federal law prohibits dietary supplements from claiming to prevent or cure disease

### Regulatory Implications

**What this means for consumers:**
- DHM supplements can be legally sold as dietary supplements
- Products **cannot claim** to prevent, treat, or cure hangovers
- No pre-market FDA approval required (follows dietary supplement framework)
- Manufacturer responsible for ensuring safety before marketing
- FDA enforcement focuses on false/misleading claims, not ingredient safety per se

### FDA Compliance Requirements

**Under 21 CFR Part 111 (Dietary Supplement cGMP):**
- Must establish specifications for identity, purity, strength, composition
- Must test for absence of contaminants (heavy metals, pesticides, microbes)
- Must follow Good Manufacturing Practices (GMP)
- Must have accurate labeling (ingredients, amounts, warnings)

### Clinical Trials

**NCT05623501:** Phase I, Dose-Escalation Study of Dihydromyricetin (DHM) is registered on ClinicalTrials.gov, indicating ongoing research into safety and efficacy.

### LiverTox Database Entry

**NCBI LiverTox** (authoritative FDA resource) notes:
- Dihydromyricetin preparations have **not been linked to instances of serum enzyme elevations or clinically apparent liver injury**
- Among 80 patients with type 2 diabetes treated with DHM (760 mg) or placebo daily for 1 month, there were "no adverse reactions" in either group

---

## 2. International Regulatory Status

### European Union (EFSA)

**Status:** âŒ NOT APPROVED as Novel Food (Application Pending)

**2020 EFSA Assessment:**
- Evaluated hot water extract of Hovenia dulcis fruits/peduncles (contains DHM)
- **Panel conclusion:** Data provided did not demonstrate batch-to-batch consistency
- **Quality control issues:** Flavonoid content in tested batches was up to **10-fold lower** than proposed specifications
- Production process contained "contradictory information"
- **Result:** Assessment identified significant quality concerns, no approval granted

**Novel Food Application (2022):**
- DHM is undergoing certification as a "Novel Food" for large-scale use in EU/UK supplements
- Petition filed by Swedish company
- **Status as of 2025:** Still pending, not yet approved

**Current Market Status:**
- DHM can be sold in some EU countries under existing regulations
- Cannot make therapeutic claims
- Legal status varies by member state

**Regulatory Pathway:**
- Would need to pass Novel Food assessment under Regulation (EU) 2015/2283
- Requires demonstration of safety and consistent quality

---

### Canada (Health Canada)

**Status:** âœ… APPROVED as Natural Health Product ingredient

**Key Evidence:**
- DHM is accepted as an ingredient in Natural Health Products (NHPs)
- At least one product has received **NPN 80122969** (Natural Product Number)
- "No Days Wasted" (Vancouver company) received approval after 5-year review process

**Approval Requirements:**
- Individual products must apply for and receive NPN before sale
- Must demonstrate safety and efficacy
- Label must be accurate and compliant with NHP regulations
- Manufacturing must follow Good Manufacturing Practices

**What this means:**
- DHM is officially recognized as safe by Health Canada
- Products can be legally sold with approved health claims (if NPN granted)
- Consumers can verify product authorization via Licensed Natural Health Products Database (LNHPD)

---

### Australia (TGA)

**Status:** âš ï¸ NOT registered as Therapeutic Good

**Key Findings:**
- DHM products are sold in Australia but **not entered on the Australian Register of Therapeutic Goods (ARTG)**
- Products explicitly disclaim: "Not sold to treat, cure or prevent any medical condition unless entered on ARTG"
- Marketed as dietary supplements or ingredients, not therapeutic goods
- Cannot make therapeutic claims under TGA regulations

**Compliance Statements on Australian Products:**
- "Dietary supplement designed to support liver health and overall wellness"
- "Not intended to diagnose, treat, cure, or prevent any disease"
- "Not to be used for therapeutic purposes"

**Verification:**
- Check ARTG database at tga.gov.au for specific product registration status
- Most DHM products sold as unregulated supplements, not registered medicines

---

### China (NMPA/formerly CFDA)

**Status:** âœ… APPROVED as New Food Ingredient (2013)

**Approval Details:**
- **Vine tea (Ampelopsis grossedentata)** approved as new food ingredient in 2013
- Approval covers vine tea extract (which naturally contains DHM)
- Traditional use in China for over 2,000 years as hangover remedy
- No specific approval found for isolated/purified DHM as pharmaceutical

**Cultural Context:**
- Vine tea is widely consumed as traditional Chinese beverage in southwest China
- Used in traditional medicine for centuries
- DHM is primary bioactive compound in vine tea

**Note:** Approval is for vine tea as food ingredient, not necessarily for DHM as isolated pharmaceutical compound.

---

### South Korea (KFDA)

**Status:** âœ… APPROVED for treatment use (2008)

**Key Finding:**
- **2008:** Dihydromyricetin was approved by Korean FDA **for use as a treatment for alcoholism**
- Represents most significant pharmaceutical approval globally
- Indicates regulatory acceptance as therapeutic agent, not just dietary supplement

---

### Japan (MHLW)

**Status:** âš ï¸ UNCLEAR - No specific information found

**Regulatory Framework:**
- Japan operates "positive list" system for food additives under Food Sanitation Act
- Only additives designated by Minister of Health, Labour and Welfare (MHLW) are permitted
- Categories: Designated additives, Existing food additives, Natural flavoring agents

**Research Gap:**
- No evidence found of Hovenia dulcis or DHM on designated/existing food additive lists
- Would require direct search of official MHLW databases to confirm status

---

## 3. Regulatory Status Summary Table

| Country/Region | Status | Classification | Approval Date | Notes |
|---------------|--------|----------------|---------------|-------|
| **United States** | âš ï¸ Allowed | Dietary Supplement | N/A | Not GRAS; FDA warns against drug claims |
| **Canada** | âœ… Approved | Natural Health Product | Ongoing | NPN 80122969 issued to at least one product |
| **European Union** | âŒ Not Approved | Novel Food (Pending) | Application pending since 2022 | EFSA raised quality concerns in 2020 |
| **Australia** | âš ï¸ Not Registered | Unregulated Supplement | N/A | Not on ARTG; no therapeutic claims allowed |
| **China** | âœ… Approved | New Food Ingredient | 2013 | Vine tea approved (contains DHM) |
| **South Korea** | âœ… Approved | Treatment for Alcoholism | 2008 | Only country with pharmaceutical approval |
| **Japan** | â“ Unclear | Unknown | N/A | No evidence found in public databases |

---

## 4. Quality Standards & Testing Requirements

### USP (United States Pharmacopeia)

**Status:** âŒ No DHM Monograph Exists

**Implications:**
- No official pharmaceutical-grade standards for DHM
- No standardized testing methods defined
- Manufacturers must establish their own quality specifications
- Seeing "USP" on a label means manufacturer *claims* to follow USP standards (not verified unless "USP Verified" seal present)

**USP Verified Program (for dietary supplements):**
- Tests for: Identity, Potency, Purity, Performance (4 P's)
- Verifies ingredients listed on label are present in correct amounts
- Tests for harmful contaminants (heavy metals, pesticides, microbes)
- Conducts facility GMP audits
- **Note:** No DHM products currently appear on USP Verified list

---

### Third-Party Certification Programs

#### NSF International

**NSF/ANSI 173 Standard** for dietary supplements includes:
- Identity and quantification of labeled ingredients
- Contaminant testing (heavy metals, pesticides, herbicides)
- Heavy metal limits: â‰¤10 Âµg/day arsenic, â‰¤6 Âµg/day lead
- cGMP facility compliance (21 CFR Part 111)
- Label accuracy verification

**Tested Contaminants:**
- Lead, arsenic, cadmium, mercury, chromium
- Pesticide and herbicide residues
- Microbiological contaminants

**DHM Products:** No specific NSF-certified DHM products identified in research.

---

#### ConsumerLab.com

**Testing Standards:**
- Stricter than FDA/industry standards (up to 40Ã— stricter for lead contamination)
- Tests for identity, potency, purity, disintegration
- Most common findings: "Lack of ingredient or poor quality ingredient" (potency issues), contamination with heavy metals/pesticides
- **Average failure rate:** ~1 in 5 supplements fail quality standards

**DHM Testing:**
- ConsumerLab has published information about DHM safety and effectiveness
- Specific testing results for DHM products available to members only (behind paywall)
- No publicly available DHM product reviews found

---

#### USP Dietary Supplement Verification Program

**Requirements:**
- Rigorous testing for quality, purity, potency, performance, consistency
- Random marketplace testing to verify ongoing compliance
- Facility audits
- Dissolution/disintegration testing

**DHM Products:** None identified with USP Verified seal.

---

### Purity Standards (Industry Practice)

**Typical Purity Levels:**
- **Commercial grade:** 50-90% DHM
- **High-purity grade:** 98-99% DHM
- **Research grade:** >99% DHM

**Purification Methods:**
- Recrystallization (8 cycles achieves 98% purity)
- High-speed counter-current chromatography (achieves >99% in 9 hours)
- Chelation extraction with ZnÂ²âº (achieves 94.3% purity)
- Supercritical fluid extraction

**Industry Standard (per suppliers):**
- â‰¥98% DHM content (HPLC analysis)
- Heavy metals testing
- Residual solvent testing
- Microbial contaminant testing

**Reality Check:**
- These are supplier claims, not third-party verified standards
- Without independent testing, purity claims are unverified
- EFSA 2020 assessment found 10-fold variation in flavonoid content between batches

---

### Heavy Metals Testing

**FDA cGMP Requirements (21 CFR Part 111):**
- Must test for contaminants including heavy metals
- Must establish acceptable limits
- Must verify each batch meets specifications

**Key Heavy Metals Tested:**
1. **Lead** - NSF limit: â‰¤6 Âµg/day
2. **Arsenic** - NSF limit: â‰¤10 Âµg/day
3. **Cadmium** - No specific limit published
4. **Mercury** - No specific limit published
5. **Chromium** - No specific limit published

**Testing Method:**
- **ICP-MS** (Inductively Coupled Plasma Mass Spectrometry)
- Detects metals at parts per trillion (ppt) levels
- Industry gold standard for heavy metal analysis

**Contamination Risk:**
- Four heavy metals (lead, mercury, arsenic, cadmium) absorbed by plants from soil
- Botanical supplements (like DHM from plant sources) at higher risk
- Testing of source material and finished product essential

**California Prop 65:**
- Stricter limits than federal regulations
- Products sold in CA must comply or carry warning label
- Eurofins and other labs offer Prop 65 compliance testing

---

### Residual Solvents Testing

**Common Extraction Solvents:**
- **Water** (hot water extraction) - safest, no residue concern
- **Ethanol** - Generally Recognized as Safe (GRAS), low concern
- **Methanol** - Toxic if residual levels exceed limits
- **n-Hexane, ethyl acetate** - Used in chromatographic purification, must be removed
- **Acetone** - Sometimes used, must be below ICH limits

**ICH Q3C Guidelines (pharmaceutical industry standard):**
- Class 1 solvents (e.g., benzene): Should be avoided
- Class 2 solvents (e.g., methanol): Limited to specific concentrations
- Class 3 solvents (e.g., ethanol, acetone): Lower toxicity, >50 mg/day acceptable

**Industry Practice:**
- Reputable manufacturers test for residual solvents
- Gas chromatography (GC) used for detection
- Certificates of Analysis (CoA) should list residual solvent results

---

### Microbiological Testing

**FDA Requirements:**
- Test for harmful microorganisms (bacteria, yeast, mold)
- Especially critical for botanical ingredients

**Standard Tests:**
- **Total Plate Count** (aerobic bacteria)
- **Yeast and Mold Count**
- **E. coli** (indicator of fecal contamination)
- **Salmonella** (pathogen, must be absent)
- **Staphylococcus aureus** (pathogen)

**NSF Limits:**
- Specific limits for microbial contaminants
- Testing follows USP-aligned methods

---

## 5. Source Material Safety

### Hovenia dulcis (Japanese Raisin Tree)

**Toxicology Profile:**

**Acute Toxicity:**
- âœ… **Safe** - No deaths or toxic side effects in mice given single oral dose up to 22 g/kg
- 14-day observation showed no abnormalities

**Chronic Toxicity:**
- âœ… **Safe** - Rats given hot water extract equivalent to 5.5-22 g/kg/day for 90 days showed no toxicity
- 13-week repeated dose toxicity study (with 4-week recovery) found no significant issues
- **Note:** EFSA noted toxicology reports lacked precise information on test material

**In Vitro Studies:**
- âœ… No cytotoxicity against various cell lines
- No hepatotoxicity on porcine liver cells (PLP2) - GIâ‚…â‚€ >400 Âµg/mL

**Herb-Drug Interactions:**
- âœ… **Minimal interaction risk** - H. dulcis fruit extracts showed negligible effects on 7 CYP isozyme activities
- Low risk of pharmacokinetic interactions when co-administered with medications

**Traditional Use:**
- Used in traditional medicine for centuries
- Generally considered safe when used in line with therapeutic practices

**EFSA 2020 Assessment Concerns:**
- Scientific evidence mainly restricted to in vitro studies
- Few in vivo toxicity studies conducted
- Lack of precise information on test materials used in safety studies

**Overall Safety Conclusion:**
- âœ… Generally safe based on available evidence
- âœ… Long history of traditional use
- âš ï¸ Limited high-quality human clinical data

---

### Ampelopsis grossedentata (Vine Tea)

**Toxicology Profile:**

**Acute Toxicity:**
- âœ… **Safe** - Single dose up to 22 g/kg in mice caused no deaths or toxic effects over 14 days
- Wistar rats given oral DHM (>95% purity) at 5.0 g/kg showed no abnormalities during 14-day observation
- No issues in sensory performance, behavioral performance, or tissue dissection

**Chronic/Long-term Toxicity:**
- âœ… **Safe** - Rats given Ampelopsis grossedentata flavonoids at 1.5 and 0.3 g/kg for 12 weeks showed no obvious toxicity
- Rats continuously gavaged with extracts at 5.5-22 g/kg/day for 90 days - safe, no adverse effects

**Clinical Studies:**
- âœ… 80 patients with type 2 diabetes treated with DHM (760 mg/day) or placebo for 1 month
- **Result:** "No adverse reactions" in either group

**Safety Profile Summary:**
- âœ… **No toxicity** observed in extensive animal testing
- âœ… **No hepatotoxicity** (liver injury) - confirmed by LiverTox database
- âœ… **No adverse reactions** in human clinical trial

**Regulatory Approval:**
- Vine tea approved as new food ingredient in China (2013)
- Edible herb in Vitaceae family
- Traditional use in southwest China for 2,000+ years

**Bioactivity (Non-Toxic Effects):**
- Antioxidant, anti-inflammatory, anti-tumor, antidiabetic, neuroprotective properties
- Wide range of beneficial bioactivities **but no toxicity**

**Overall Safety Conclusion:**
- âœ… Excellent safety profile
- âœ… No significant toxicity in animal or human studies
- âœ… Approved for food use in China

---

### Sustainable Harvesting & Environmental Concerns

**Research Gap:**
- Limited public information on sustainable harvesting practices
- No evidence of Hovenia dulcis or Ampelopsis grossedentata being endangered species
- Both plants cultivated for commercial extraction

**Pesticide Residues:**
- Botanical ingredients at risk of pesticide contamination
- Quality manufacturers should test for:
  - Organophosphate pesticides
  - Organochlorine pesticides
  - Pyrethroids
- Third-party certifications (NSF, USP) include pesticide testing

---

## 6. Manufacturing Standards

### Good Manufacturing Practices (GMP)

**FDA Requirements (21 CFR Part 111):**

All dietary supplement manufacturers must follow current Good Manufacturing Practices (cGMP):

**Key Requirements:**
1. **Personnel:** Qualified staff, trained in cGMP procedures
2. **Physical Plant:** Clean, sanitary facility; pest control; waste management
3. **Equipment:** Appropriate design; properly maintained and calibrated
4. **Production and Process Controls:**
   - Establish specifications for identity, purity, strength, composition
   - Test incoming ingredients
   - Test finished products
   - Prevent contamination and mix-ups
5. **Quality Control:**
   - Test each batch before release
   - Establish product specifications
   - Retain samples for testing
6. **Documentation:**
   - Batch records
   - Testing records
   - Complaint files
7. **Adverse Event Reporting:** Report serious adverse events to FDA

**Common GMP Deficiencies (FDA Inspections):**
- Insufficient specifications for identity, purity, strength
- Inadequate contaminant testing
- Poor quality control procedures
- Lack of proper documentation

---

### NSF GMP Certification

**NSF/ANSI 173 Section 8:** On-site facility inspections to audit compliance with FDA cGMP

**What NSF GMP Audit Covers:**
- Facility sanitation and organization
- Equipment calibration and maintenance
- Raw material testing and verification
- Finished product testing
- Label accuracy
- Batch record documentation
- Staff training and qualifications

---

### International Standards

**ISO 22000** (Food Safety Management):
- International standard for food safety
- Some supplement manufacturers pursue this certification
- Demonstrates commitment to safety and quality

**Organic Certifications:**
- USDA Organic (for organic-certified ingredients)
- EU Organic
- **Note:** Organic certification does NOT guarantee purity or potency, only farming practices

---

## 7. Extraction Methods & Solvent Safety

### Common Extraction Methods

#### 1. Hot Water Extraction
- **Process:** Dried plant material extracted with hot water in batch process
- **Solvents:** Water only
- **Safety:** âœ… Safest method, no solvent residue concerns
- **Purity:** Typically lower (yields crude extract with multiple compounds)
- **Pros:** Natural, safe, traditional method
- **Cons:** Lower DHM concentration, requires further purification

#### 2. Ethanol/Alcohol Extraction
- **Process:** Plant material soaked in ethanol, then solvent evaporated
- **Solvents:** Ethanol (GRAS substance)
- **Safety:** âœ… Generally safe; ethanol is food-grade
- **Purity:** Moderate to high (depends on purification steps)
- **Pros:** Efficient extraction, relatively safe solvent
- **Cons:** Requires evaporation step; residual ethanol must be monitored

#### 3. Methanol Extraction (Soxhlet)
- **Process:** Continuous extraction using methanol in Soxhlet apparatus
- **Solvents:** Methanol (toxic if residues remain)
- **Safety:** âš ï¸ Requires testing for residual methanol (ICH Class 2 solvent)
- **Purity:** Moderate
- **Pros:** Efficient for research purposes
- **Cons:** Methanol toxicity concern; must be removed completely

#### 4. Ultrasound-Assisted Extraction (UAE)
- **Process:** Ultrasonic waves create cavitation bubbles that disrupt cell walls
- **Solvents:** Water, ethanol, or combination
- **Safety:** âœ… Safe (depends on solvent used)
- **Purity:** High
- **Pros:** Faster, higher yield, better efficiency than traditional methods
- **Cons:** Requires specialized equipment

#### 5. Chromatographic Purification
- **Process:** Crude extract purified using column chromatography (e.g., high-speed counter-current chromatography)
- **Solvents:** n-hexane, ethyl acetate, methanol, water (solvent system varies)
- **Safety:** âš ï¸ Must test for residual solvents
- **Purity:** Highest (>99% achievable in 9 hours)
- **Pros:** Pharmaceutical-grade purity
- **Cons:** Expensive, used for research-grade DHM

#### 6. Chelation Extraction (Novel Method)
- **Process:** ZnÂ²âº introduced to chelate with DHM
- **Solvents:** Varies
- **Safety:** âš ï¸ Requires verification that zinc is removed
- **Purity:** ~94.3%
- **Pros:** Innovative approach, high purity
- **Cons:** Novel method, not widely adopted

---

### Solvent Residue Safety

**Key Principle:** Extraction solvent must be removed to safe levels before human consumption.

**Safe Solvents (minimal concern if trace amounts remain):**
- Water
- Ethanol (GRAS)
- Acetic acid (food-grade)

**Solvents Requiring Testing:**
- Methanol (ICH Class 2 - limit: â‰¤300 ppm)
- Acetone (ICH Class 3 - limit: â‰¤500 ppm)
- Ethyl acetate (ICH Class 3 - limit: â‰¤500 ppm)
- n-Hexane (ICH Class 2 - limit: â‰¤29 ppm)

**Red Flag Solvents (should be avoided):**
- Benzene (ICH Class 1 - carcinogenic)
- Carbon tetrachloride (ICH Class 1 - toxic)

**Verification:**
- Reputable manufacturers should provide **Certificate of Analysis (CoA)** showing residual solvent testing results
- Testing method: **Gas Chromatography (GC)**

---

## 8. Bioavailability & Formulation Quality

### The Bioavailability Problem

**Critical Issue:** DHM has **extremely poor oral bioavailability**

**Key Data:**
- **Oral bioavailability in rats: Only 4.02%**
- **Water solubility: Only 0.2 mg/mL at 25Â°C**
- **Classification:** BCS Class IV drug (low solubility + low membrane permeability)

**What This Means for Consumers:**
- Taking 300 mg DHM capsule = only ~12 mg absorbed into bloodstream
- Most DHM passes through digestive system without absorption
- **Formulation matters enormously** - poorly formulated products may have negligible effects

---

### Stability Issues

**Chemical Instability:**
- Phenol hydroxyl groups make DHM chemically unstable
- **Oxidation** is main cause of degradation
- **pH-dependent stability:**
  - âœ… Stable in stomach (acidic environment)
  - âŒ Unstable in duodenum, small intestine, colon (alkaline pH)

**Storage Concerns:**
- DHM degrades over time if not properly formulated/packaged
- Exposure to light, heat, moisture accelerates degradation

---

### Advanced Formulations to Improve Bioavailability

**Why This Matters:** Standard DHM powder/capsules have 4% bioavailability. Advanced formulations can improve this **5-10Ã— or more**.

#### 1. Cocrystals with Crystallization Inhibitors
- **Bioavailability improvement:** ~5-fold enhancement
- **Method:** DHM cocrystallized with polyvinylpyrrolidone K30 (PVP)
- **Mechanism:** Inhibits precipitation in GI tract, keeping DHM in solution longer
- **Salt-cocrystal with ciprofloxacin:** 8-fold bioavailability enhancement

#### 2. Nanoparticle Systems
- **Technology:** DHM embedded in zein-caseinate nanoparticles
- **Bioavailability improvement:** Significant increase in rats
- **Mechanism:** Improved adhesion and retention time in GI tract; enhanced absorption

#### 3. Microemulsions
- **Drug release:** 72.34% (vs. 36.28% for plain suspension)
- **Limitation:** Not as effective due to DHM's low membrane permeability
- **Note:** Improved solubility â‰  improved absorption for BCS Class IV drugs

#### 4. Gastric Floating Pills
- **Strategy:** Retain DHM in acidic stomach environment where it's stable
- **Mechanism:** Selective and sustained absorption in stomach
- **Pros:** Avoids alkaline intestine where DHM degrades
- **Technology:** Floating drug carriers stay in stomach longer

#### 5. Other Technologies (Research Stage)
- **Solid dispersions**
- **Nanocapsules**
- **Cyclodextrin inclusion complexes**
- **Phospholipid complexes**
- **Chemical/enzymatic acylation**

---

### How to Identify Quality Formulations

**Red Flags (Likely Poor Bioavailability):**
- Plain DHM powder in capsule with no excipients
- No mention of enhanced absorption/bioavailability
- Only lists "DHM 98% purity" with no formulation details
- Extremely cheap products (suggests no investment in formulation)

**Good Signs (Better Bioavailability):**
- Mentions "enhanced bioavailability" or "liposomal" or "nanoparticle"
- Contains absorption enhancers (e.g., piperine, PVP, lecithin)
- Formulated with fats/oils (improves solubility)
- Enteric coating (protects from alkaline pH degradation)
- Product backed by pharmacokinetic studies

**Gold Standard:**
- Clinical studies showing blood levels of DHM after dosing
- Pharmacokinetic data (Cmax, AUC, Tmax)
- Comparative bioavailability testing vs. plain DHM

---

## 9. Red Flags When Buying DHM Supplements

### Critical Warning Signs

#### ðŸš© No Third-Party Testing
- **Red Flag:** No mention of independent lab testing
- **Why It Matters:** Manufacturer's own testing may be unreliable or fabricated
- **What to Look For:** NSF Certified, USP Verified, ConsumerLab Approved, or independent lab CoA

#### ðŸš© No Certificate of Analysis (CoA)
- **Red Flag:** Company won't provide CoA upon request
- **Why It Matters:** CoA shows actual test results (purity, contaminants, identity)
- **What to Look For:** Accessible CoA with batch-specific results (not generic)

#### ðŸš© Proprietary Blends
- **Red Flag:** "Proprietary blend 500 mg" without individual ingredient amounts
- **Why It Matters:** You don't know how much DHM you're actually getting
- **What to Look For:** Specific DHM content per serving (e.g., "300 mg DHM per capsule")

#### ðŸš© Unrealistic Health Claims
- **Red Flag:** "Cures hangovers," "Prevents liver damage," "FDA-approved for alcohol recovery"
- **Why It Matters:** Illegal drug claims; suggests unethical company
- **What to Look For:** Conservative, evidence-based language ("may support liver health," "traditionally used for...")

#### ðŸš© No GMP Certification
- **Red Flag:** No mention of GMP compliance or facility certifications
- **Why It Matters:** Suggests poor manufacturing standards, contamination risk
- **What to Look For:** "Manufactured in FDA-registered, cGMP-compliant facility" or NSF GMP Certified

#### ðŸš© Extremely Low Price
- **Red Flag:** DHM significantly cheaper than competitors
- **Why It Matters:** Quality raw material, testing, and formulation cost money
- **What to Look For:** Mid-range pricing; extreme discounts suggest compromised quality

#### ðŸš© No Transparency on Source
- **Red Flag:** Doesn't specify plant source (Hovenia dulcis vs. Ampelopsis grossedentata) or origin
- **Why It Matters:** Source material quality varies; China-sourced may have pesticide/heavy metal risks
- **What to Look For:** "Sourced from [specific plant]," "Grown in [country]," "Tested for pesticides"

#### ðŸš© No Batch/Lot Number
- **Red Flag:** Bottle has no lot number or expiration date
- **Why It Matters:** Can't trace product back to specific production batch if issues arise
- **What to Look For:** Clear lot number and expiration date on packaging

#### ðŸš© Purity Not Specified
- **Red Flag:** Label says "DHM 300 mg" but doesn't specify % purity
- **Why It Matters:** 300 mg of 50% pure DHM = only 150 mg actual DHM
- **What to Look For:** "DHM â‰¥98% purity" or "300 mg pure DHM"

#### ðŸš© Amazon/Third-Party Seller Only
- **Red Flag:** Only sold via Amazon/eBay, no company website
- **Why It Matters:** Hard to verify company legitimacy; easier for sellers to disappear
- **What to Look For:** Established company website with contact info, history, transparency

---

### Certifications That Matter vs. Marketing Fluff

#### âœ… Certifications That Actually Mean Something

**1. NSF Certified for Sport / NSF/ANSI 173**
- **Verified:** Third-party testing for contaminants, label accuracy, GMP compliance
- **How to Check:** nsf.org certification database

**2. USP Verified**
- **Verified:** Rigorous testing for identity, potency, purity, performance
- **How to Check:** usp.org/verification-services (search verified products)

**3. ConsumerLab Approved**
- **Verified:** Independent testing; stricter standards than FDA
- **How to Check:** consumerlab.com (membership required for full access)

**4. cGMP Certified (by third party like NSF)**
- **Verified:** Facility audited for compliance with FDA manufacturing standards
- **How to Check:** Look for audit certificate or NSF GMP registration

**5. Informed Choice / Informed Sport**
- **Verified:** Batch-tested for banned substances (for athletes)
- **How to Check:** informed-choice.org or informed-sport.com

#### âš ï¸ Marketing Terms That Mean Little

**"Laboratory Tested"**
- **Reality:** Could be manufacturer's own lab (not independent)
- **Better:** "Third-party tested by [specific lab name]"

**"Pharmaceutical Grade"**
- **Reality:** No legal definition for supplements; meaningless marketing term
- **Better:** Actual purity % and testing data

**"FDA Approved"**
- **Reality:** FDA does not approve dietary supplements
- **Better:** "Manufactured in FDA-registered facility"

**"All Natural"**
- **Reality:** Doesn't guarantee purity, safety, or effectiveness
- **Better:** Specific source information and testing data

**"Clinical Strength"**
- **Reality:** No standardized definition
- **Better:** Dose backed by published clinical studies

**"Made in USA"**
- **Reality:** Raw material could still be imported from China
- **Better:** "Sourced and manufactured in USA" + CoA showing origin

---

## 10. How to Evaluate DHM Supplement Quality (Consumer Checklist)

### Before Purchasing

**Step 1: Check Company Transparency**
- [ ] Company has established website with contact information
- [ ] Lists manufacturing facility location and certifications
- [ ] Provides clear information about sourcing and testing
- [ ] Has been in business for >2 years (check domain registration date)

**Step 2: Verify Third-Party Testing**
- [ ] Claims third-party testing by named lab (not just "lab tested")
- [ ] Provides Certificate of Analysis (CoA) accessible on website or upon request
- [ ] CoA is batch-specific (not generic) with lot number matching product
- [ ] CoA includes testing for: Purity (HPLC), Heavy metals (ICP-MS), Microbial contaminants

**Step 3: Evaluate Manufacturing Standards**
- [ ] Manufactured in cGMP-compliant facility (21 CFR Part 111)
- [ ] Ideally NSF GMP certified or audited by third party
- [ ] FDA-registered facility (check FDA database if skeptical)

**Step 4: Assess Product Formulation**
- [ ] States specific DHM content per serving (e.g., "300 mg DHM")
- [ ] States purity level (â‰¥98% ideal)
- [ ] Plant source identified (Hovenia dulcis or Ampelopsis grossedentata)
- [ ] Mentions bioavailability enhancement (if advanced formulation)
- [ ] No proprietary blends hiding actual DHM amount

**Step 5: Review Labeling & Claims**
- [ ] Label is clear, professional, and compliant
- [ ] No illegal drug claims ("cures," "treats," "prevents" disease)
- [ ] Includes lot number and expiration date
- [ ] Supplement Facts panel is complete and accurate
- [ ] Allergen warnings if applicable

**Step 6: Check for Red Flags**
- [ ] No unrealistic promises or miracle cure language
- [ ] Price is reasonable (not suspiciously cheap)
- [ ] Company responds to inquiries professionally
- [ ] No pattern of negative reviews citing contamination or illness
- [ ] Not solely sold via marketplace (Amazon/eBay) with no traceable company

**Step 7: Request Documentation**
- [ ] Contact company and request Certificate of Analysis for specific lot
- [ ] Ask about heavy metals testing results
- [ ] Ask about extraction method and residual solvent testing
- [ ] Evaluate responsiveness and transparency of answers

---

### After Purchasing

**Step 1: Visual Inspection**
- [ ] Lot number on bottle matches CoA (if provided)
- [ ] Seal is intact and unbroken
- [ ] Capsules/powder appear uniform in color and consistency
- [ ] No off smells, discoloration, or clumping

**Step 2: Verify Batch Documentation**
- [ ] Search product lot number on company website
- [ ] Request CoA for your specific batch
- [ ] Confirm test date is recent (<6 months old for CoA)

**Step 3: Monitor for Effects & Safety**
- [ ] Start with lower dose to assess tolerance
- [ ] Monitor for any adverse effects
- [ ] Evaluate effectiveness over 2-4 weeks
- [ ] Report serious adverse events to FDA MedWatch (if applicable)

---

## 11. Recommendations for Consumers

### Finding High-Quality, Safe DHM Supplements

**Priority 1: Third-Party Tested Products**
- Look for NSF Certified, USP Verified, or ConsumerLab Approved products
- If none available, choose brands that provide accessible, batch-specific CoAs

**Priority 2: Verify Purity & Potency**
- Select products with â‰¥98% DHM purity
- Ensure specific DHM content per serving is listed (not hidden in proprietary blend)
- Verify via CoA that purity claim is tested and accurate

**Priority 3: Manufacturing Quality**
- Choose products from cGMP-certified facilities
- Ideally NSF GMP certified or third-party audited
- Verify facility is FDA-registered (not "FDA-approved")

**Priority 4: Safety Testing**
- Confirm product is tested for heavy metals (lead, arsenic, cadmium, mercury)
- Verify pesticide screening (especially for botanical source)
- Check microbiological testing results (bacteria, yeast, mold)

**Priority 5: Formulation for Bioavailability**
- Consider advanced formulations (nanoparticles, liposomal, cocrystals) if available
- Plain DHM powder has only 4% bioavailability - may be ineffective
- Look for products mentioning bioavailability enhancement

**Priority 6: Transparency & Ethics**
- Choose companies with transparent sourcing and testing practices
- Avoid companies making illegal drug claims or unrealistic promises
- Support brands that invest in clinical research and publish data

---

### Specific Product Recommendations (Based on Research)

**Note:** This report does not endorse specific brands, but provides criteria to evaluate products.

**Look for products that:**
1. Are third-party tested (NSF, USP, or ConsumerLab)
2. Provide batch-specific CoA with heavy metals testing
3. Specify â‰¥98% DHM purity
4. Are manufactured in cGMP-certified facilities
5. State clear DHM content per serving (e.g., 300-500 mg)
6. Source from Hovenia dulcis or Ampelopsis grossedentata
7. Ideally use bioavailability-enhancing formulation
8. Make conservative, evidence-based claims
9. Have responsive customer service
10. Have established reputation (>2 years in business)

**If no DHM products meet all criteria:**
- Prioritize third-party testing and transparency over other factors
- Request CoA before purchasing
- Start with smaller quantity to assess quality before bulk buying

---

### Regulatory & Safety Summary for Consumers

**âœ… DHM is generally safe based on:**
- Extensive animal toxicology studies showing no acute or chronic toxicity
- Human clinical trial (80 patients, 1 month) showing no adverse reactions
- Traditional use for 2,000+ years in China
- No reported cases of liver injury (LiverTox database)

**âš ï¸ Regulatory status is mixed:**
- US: Allowed as dietary supplement, but cannot make hangover cure claims
- Canada: Approved (at least one product has NPN)
- EU: Not approved as novel food (application pending, quality concerns raised)
- Australia: Not registered as therapeutic good
- China: Vine tea approved as food ingredient (2013)
- South Korea: Approved for alcoholism treatment (2008)

**âŒ Quality control is a major concern:**
- No USP monograph or official quality standards
- Third-party certification is rare
- EFSA found 10-fold variation in batch quality
- Many products lack independent testing
- Bioavailability is poor (4%) without advanced formulation

**ðŸŽ¯ Consumer Action Steps:**
1. **Verify third-party testing** - Don't trust manufacturer's claims alone
2. **Request Certificate of Analysis** - Reputable companies will provide it
3. **Check for GMP certification** - Ensures basic manufacturing quality
4. **Evaluate bioavailability** - Plain DHM powder likely ineffective
5. **Avoid illegal claims** - Companies making drug claims are unethical
6. **Start low, go slow** - Assess tolerance and effectiveness
7. **Report adverse events** - Use FDA MedWatch if problems occur

---

## 12. Research Gaps & Future Outlook

### Areas Lacking Sufficient Data

**1. Long-term Human Safety**
- Most clinical data is short-term (1 month)
- No long-term (>1 year) human safety studies published
- Chronic use safety not well-established

**2. Drug Interactions**
- Limited data on interactions with common medications
- Minimal CYP enzyme interaction found, but more research needed
- Theoretical interaction with alcohol metabolism (intended effect, but needs monitoring)

**3. Special Populations**
- No safety data in pregnancy or breastfeeding
- Limited data in children/adolescents
- No data in elderly or those with liver/kidney disease

**4. Quality Control Standards**
- No official pharmacopeial monograph (USP, EP, BP)
- No internationally harmonized quality standards
- Batch-to-batch consistency remains concern (per EFSA 2020)

**5. Optimal Dosing**
- No established effective dose range in humans for specific outcomes
- Bioavailability issues mean dose response unclear
- Formulation dramatically affects required dose

**6. Comparative Effectiveness**
- No head-to-head studies of different DHM products/formulations
- No data comparing bioavailability of commercial products
- Consumer cannot reliably compare products

---

### Regulatory Outlook

**European Union:**
- Novel food application pending since 2022
- EFSA quality concerns must be addressed by applicant
- Approval uncertain; may take several more years
- If approved, will set quality/safety precedent

**United States:**
- Unlikely to receive GRAS designation without industry petition and extensive safety data
- FDA will continue to enforce against illegal drug claims
- Third-party certification may increase as market grows
- Possible NDI notification if companies pursue it

**Australia:**
- Could apply for TGA registration as complementary medicine
- Requires evidence of efficacy and safety
- Process is lengthy and expensive
- Current supplement market will likely continue

**International Harmonization:**
- DHM could be included in future international pharmacopeias if quality data standardized
- WHO or other bodies could develop monograph if clinical evidence grows

---

### Industry Trends

**1. Bioavailability Enhancement**
- Expect more products with advanced formulations (nanoparticles, liposomal, cocrystals)
- Companies that solve bioavailability problem will dominate market

**2. Clinical Research**
- More human clinical trials likely (Phase I study ongoing)
- Focus on liver health, alcohol metabolism, metabolic disorders
- Published data will drive regulatory decisions

**3. Third-Party Certification**
- Market pressure may push more companies to pursue NSF/USP certification
- Consumers increasingly demand transparency and testing

**4. Quality Standardization**
- Industry may self-regulate to establish quality standards
- Trade associations could develop best practices

**5. Combination Products**
- DHM often combined with NAC, milk thistle, B vitamins, electrolytes
- Synergistic formulations may improve effectiveness

---

## 13. Conclusion

Dihydromyricetin (DHM) is a naturally-derived compound with a strong safety profile based on toxicology studies and traditional use, but it exists in a complex regulatory landscape with significant quality control challenges. While it can be legally sold as a dietary supplement in several countries, it lacks official approval as a novel food in the EU and has no GRAS designation in the US.

**For consumers seeking high-quality DHM supplements, the key is due diligence:**
- Demand third-party testing and Certificates of Analysis
- Verify GMP manufacturing standards
- Choose products with specified purity (â‰¥98%) and potency
- Consider bioavailability-enhanced formulations
- Avoid products making illegal drug claims
- Start with reputable companies that invest in transparency and testing

**The DHM market is evolving.** As clinical research expands and regulatory frameworks develop, quality standards will likely improve. Until then, consumers must be informed advocates for their own safety and effectiveness by carefully evaluating products against the criteria outlined in this report.

---

## 14. References & Resources

### Regulatory Agencies

**United States:**
- FDA Dietary Supplements: https://www.fda.gov/food/dietary-supplements
- FDA Warning Letters: https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters
- ClinicalTrials.gov: https://clinicaltrials.gov/study/NCT05623501
- LiverTox (NCBI): https://www.ncbi.nlm.nih.gov/books/NBK594407/

**Canada:**
- Health Canada Natural Health Products: https://www.canada.ca/en/health-canada/services/drugs-health-products/natural-non-prescription.html
- Licensed Natural Health Products Database: https://health-products.canada.ca/lnhpd-bdpsnh/

**European Union:**
- EFSA Novel Foods: https://www.efsa.europa.eu/en/topics/topic/novel-food
- EFSA 2020 Hovenia dulcis Assessment: https://www.efsa.europa.eu/en/efsajournal/pub/6196

**Australia:**
- Therapeutic Goods Administration: https://www.tga.gov.au/
- ARTG Database: https://www.tga.gov.au/resources/artg

### Third-Party Testing Organizations

- **NSF International:** https://www.nsf.org/
- **USP (U.S. Pharmacopeia):** https://www.usp.org/
- **ConsumerLab.com:** https://www.consumerlab.com/

### Scientific Databases

- **PubMed:** https://pubmed.ncbi.nlm.nih.gov/
- **PubMed Central (PMC):** https://pmc.ncbi.nlm.nih.gov/

### Key Scientific Reviews

1. "Dihydromyricetin: A review on identification and quantification methods, biological activities, chemical stability, metabolism and approaches to enhance its bioavailability" - PMC7127391
2. "Hovenia dulcis Thumberg: Phytochemistry, Pharmacology, Toxicology and Regulatory Framework for Its Use in the European Union" - PMC7914479
3. "Vine tea (Ampelopsis grossedentata): A review of chemical composition, functional properties, and potential food applications" - Journal of Future Foods, 2021
4. "Strategic developments in the drug delivery of natural product dihydromyricetin: applications, prospects, and challenges" - PMC9518266

---

**Report Prepared:** November 9, 2025
**Researcher:** Claude (Anthropic AI)
**Methodology:** Comprehensive web search across regulatory databases, scientific literature, third-party testing organizations, and industry sources

**Disclaimer:** This report is for informational purposes only and does not constitute medical or legal advice. Consumers should consult healthcare providers before using DHM supplements, especially if pregnant, nursing, taking medications, or have medical conditions. Regulatory status may change over time; verify current regulations with appropriate authorities.
